Refractory Hypoglycaemia in DiabetesRefractory Hypoglycaemia in Diabetes
Read about a case of severe refractory hypoglycemia in a patient on oral hypoglycemics and ciprofloxacin. The British Journal of Diabetes and Vascular Disease (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Risk Of Kidney Disease Doubled With Use Of Fluoroquinolone Antibiotics
The risk of acute kidney disease is doubled for people taking oral fluoroquinolone antibiotics, according to a study of published in CMAJ (Canadian Medical Association Journal). Fluoroquinolones, including ciprofloxacin, levofloxacin and moxifloxacin, are common broad-spectrum antibiotics most often used to treat respiratory and urogenital infections. Case reports have indicated acute kidney injury with use, and prescription labels carry a warning of kidney failure. However, when oral fluoroquinolones are prescribed in clinical practice, kidney injury is usually not considered... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 3, 2013 Category: Consumer Health News Tags: Urology / Nephrology Source Type: news
SALVAT completes enrolment for Phase III study of acute otitis media drug
Spanish pharmaceutical group SALVAT has finished enrolling patients with acute otitis media (middle ear infection) in its Phase III study designed to assess the efficacy and safety of a new otic solution comprising ciprofloxacin and fluocinolone. (Source: Drug Development Technology)
Source: Drug Development Technology - May 28, 2013 Category: Pharmaceuticals Source Type: news
Venus Remedies signs deal with Korean co for antibiotic drug
The deal was signed after Companies and Intellectual Property Registration Office (CIPRO) of Republic of South Korea granted the patent to the product. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 2, 2013 Category: Pharmaceuticals Source Type: news
Moxifloxacin versus ciprofloxacin plus co-amoxiclav for fever in low-risk neutropoenic patients with cancer
Source: Journal of Clinical Oncology
Area: News
According to the results of a double-blind RCT, monotherapy with once daily oral moxifloxacin is associated with similar efficacy to ciprofloxacin plus co-amoxiclav combination therapy in the treatment of fever in adults with cancer and neutropoenia who are deemed to be at low-risk of complications.
The authors note that prompt empirical antibiotic therapy for fever in patients with neutropenia has become the standard of care; current guidelines recommend oral ciprofloxacin plus co-amoxiclav as the standard regimen for those who are low-risk. The purpose of the c...
Source: NeLM - News - January 29, 2013 Category: Drugs & Pharmacology Source Type: news
South Africa drug authority approves Marck's 6 products
Six products have obtained approvals from MCC-South Africa, including Sterile Water for injections and Ciprofloxacin Eye Drops among others. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 4, 2013 Category: Pharmaceuticals Source Type: news
Cholera and Diarrhea
CHOLERA and DIARRHEA
At this very moment there is an outbreak of cholera in Zimbabwe– not a worldwide pandemic, but a localized epidemic. This is not a trivial point of interest, but a major news event that will not only have a dramatic impact on the population of Zimbabwe but also on the entire world as the aftermath of this epidemic will require international aid. Cholera will most likely kill thousands of people in Zimbabwe, impact tens of thousands of lives, and will continue to be a constant threat around the world and a very real concern for the adventurous and international travelers.
What is cholera?
Cholera...
Source: Wilderness Medicine Newsletter - January 1, 2009 Category: Rural Health Authors: wildernessmedicinenewsletter Tags: Cholera Diarrhea Source Type: news
